ONCOLOGY VENTURE- Q&A D.6/11-2019 - TRANSCRIPT
-
Transcript på dagens Q&A med CFO Henrik Moltke.
-
Gode takter i dag fra OV
Et par overskrifter fra dagens PM:
Oncology Venture A/S: Oncology Venture reaches new development milestone with Dovitinib.
og
Oncology Venture A/S: Oncology Venture advancing towards next milestone in its clinical development of 2X-121
Er ikke selv inde i det teknologiske men idéen med at præcicere hvilken medicin der virker på hvilke kræftpatienter virker meget interessant.
-
Interessant interview
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind